期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
基质干细胞及明胶微载体植入大鼠心脏的研究 被引量:1
1
作者 常静 雷寒 贾锋鹏 《第三军医大学学报》 CAS CSCD 北大核心 2006年第6期507-511,共5页
目的 探讨将来源于人类胚胎肝脏的基质干细胞(human fetal liver-delivered mesenchymal stem cells,HFMSCs)及明胶多孔微载体植入正常心肌组织促使心肌及微循环再生的可行性。方法 将SD大鼠分为细胞植入组(n=9)、微载体植入组(n=... 目的 探讨将来源于人类胚胎肝脏的基质干细胞(human fetal liver-delivered mesenchymal stem cells,HFMSCs)及明胶多孔微载体植入正常心肌组织促使心肌及微循环再生的可行性。方法 将SD大鼠分为细胞植入组(n=9)、微载体植入组(n=9)和对照组(n=4),分别在左心室室壁内注射80—100μl含HFMSCs的perfadex溶液、含微载体的perfadex溶液或单纯perfadex溶液。用超声心动图评定移植前后大鼠心脏功能,并分别于术后7、14d取出心肌组织作原位杂交、HE染色、免疫组化染色及混合淋巴细胞培养(MLC)。结果 细胞植入7d后,心脏功能有显著的增加,原位杂交显示,有较多细胞在心肌组织中存活,但免疫组化染色未发现植入细胞向心肌细胞方向的分化;至移植后第14天,移植细胞从心肌组织中消失,在注射局部发现大量巨噬细胞浸润,而体外MLC证实,此时HFMSCs有诱导sD大鼠内淋巴细胞增殖的效应。微载体植入7、14d后,心脏功能无明显增加,微载体仍集中在注射部位,并保持原有形状,其上有较多细胞生长贴附,免疫组化染色显示,这些细胞既不是心肌细胞,也不是毛细血管。结论 HFMSCs植入正常大鼠心脏组织中能短期存活并促进心脏功能增加,但因慢性免疫排斥反应,移植细胞在发生心肌分化之前在体内逐渐消失;明胶多孔微载体植入正常心肌组织后,不能促进心脏功能增加,也不能促使心肌及其微循环生长于其中。 展开更多
关键词 基骨质干细胞 明胶多孔微载体 心肌再生 微循环再生
在线阅读 下载PDF
Preparation of new tissue engineering bone-CPC/PLGA composite and its application in animal bone defects 被引量:3
2
作者 郑治 王剑龙 +4 位作者 米雷 刘咏 侯光辉 陈旦 黄伯云 《Journal of Central South University》 SCIE EI CAS 2010年第2期202-210,共9页
To investigate the feasibility of implanting the biocomposite of calcium phosphate cement(CPC)/polylactic acid-polyglycolic acid(PLGA) into animals for bone defects repairing,the biocomposite of CPC/PLGA was prepared ... To investigate the feasibility of implanting the biocomposite of calcium phosphate cement(CPC)/polylactic acid-polyglycolic acid(PLGA) into animals for bone defects repairing,the biocomposite of CPC/PLGA was prepared and its setting time,compressive strength,elastic modulus,pH values,phase composition of the samples,degradability and biocompatibility in vitro were tested.The above-mentioned composite implanted with bone marrow stromal cells was used to repair defects of the radius in rabbits.Osteogenesis was histomorphologically observed by using an electron-microscope.The results show that compared with the CPC,the physical and chemical properties of CPC/PLGA composite have some differences in which CPC/PLGA composite has better biological properties.The CPC/PLGA composite combined with seed cells is superior to the control in terms of the amount of new bones formed after CPC/PLGA composite is implanted into the rabbits,as well as the speed of repairing bone defects.The results suggest that the constructed CPC/PLGA composite basically meets the requirements of tissue engineering scaffold materials and that the CPC/PLGA composite implanted with bone marrow stromal cells may be a new artificial bone material for repairing bone defects because it can promote the growth of bone tissues. 展开更多
关键词 BIOMATERIALS mesenchymal stem cells (MSCs) calcium phosphate cement (CPC) polylactic acid-polyglycolic acid (PLGA) bone defects
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部